PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership
PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
PostNews
BioStock: PHI charts a bold course to impact regenerative medicine
BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
PostNews
BioStock: The five best life science stocks of the first half-year
PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
PostNews: Press Release
European Patent Office intends to grant PHI patent on synthetic antibodies
PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
PostNews
BioStock: PHI’s CEO reflects on global roadshow success
BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.
PostNews: Interim Report
Interim Report 4 2022/23
Sales continue to grow, and the year ended up with the highest turnover for a year in PHI, so far.
